Clinical trial / 2018
Combined resveratrol and curcumin supplementation did not alter the postprandial inflammatory response to a high-fat meal in older adults with abdominal obesity.
In a randomized, double-blind crossover trial, 22 older adults with abdominal obesity underwent a 6-hour oral fat tolerance test after consuming either a supplement (200 mg resveratrol and 100 mg curcumin) or a placebo. Supplementation did not modify postprandial variations in circulating inflammatory markers (CRP, IL-6, IL-8, MCP-1) or adhesion molecules (sE-selectin, sVCAM-1, sICAM-1) compared to placebo (P Treatment×Time > 0.05). However, the supplement significantly reduced the cumulative postprandial response of sVCAM-1 (incremental area under the curve -4643%, P = 0.01), while whole-blood PPARA and NFKB1 gene expressions were unchanged.
- Study type
- Double-blind, crossover, randomized, placebo-controlled trial
- Who was studied
- 11 men and 11 postmenopausal women with abdominal obesity (age 62 ± 5 y; BMI 29 ± 3 kg/m2)
- What was measured
- Resveratrol bioavailability, inflammatory markers, adhesion molecules, and whole blood NFκB1/PPARA gene expression after a high-fat meal
THE PAPER
Supplementation with Resveratrol and Curcumin Does Not Affect the Inflammatory Response to a High-Fat Meal in Older Adults with Abdominal Obesity: A Randomized, Placebo-Controlled Crossover Trial.
Vors C, Couillard C, Paradis ME, Gigleux I, Marin J, Vohl MC, Couture P, Lamarche B. J Nutr, 2018.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.